These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 35102778)

  • 21. Temporal Outcomes after Rituximab Therapy for Pemphigus Vulgaris.
    Tovanabutra N; Bax CE; Feng R; Kushner CJ; Payne AS
    J Invest Dermatol; 2022 Apr; 142(4):1058-1064.e7. PubMed ID: 34710389
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of refractory pemphigus vulgaris with anti-CD20 monoclonal antibody (rituximab): five cases.
    Antonucci A; Negosanti M; Tabanelli M; Varotti C
    J Dermatolog Treat; 2007; 18(3):178-83. PubMed ID: 17538808
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of Pemphigus Vulgaris and Foliaceus with Adjuvant Rituximab Compared to Immunosuppression Alone: Real-Life Experience.
    Snast I; Spitzer L; Hodak E; Levi A; Mimouni D; Leshem YA
    Dermatology; 2021; 237(2):179-184. PubMed ID: 32756069
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment of severe refractory pemphigus vulgaris with rituximab].
    Pitarch G; Sánchez-Carazo JL; Pardo J; Torrijos A; Roche E; Fortea JM
    Actas Dermosifiliogr; 2006; 97(1):48-51. PubMed ID: 16540052
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pemphigus vulgaris affecting 19 nails.
    Patsatsi A; Sotiriou E; Devliotou-Panagiotidou D; Sotiriadis D
    Clin Exp Dermatol; 2009 Mar; 34(2):202-5. PubMed ID: 18795937
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rituximab treatment of pemphigus in women of childbearing age: experience with two patients.
    Lake EP; Huang YH; Aronson IK
    J Dermatolog Treat; 2017 Dec; 28(8):751-752. PubMed ID: 27796136
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The management of pemphigus vulgaris in a burn intensive care unit: a case report and treatment review.
    Miletta N; Miller ME; Lam T; Chung KK; Hivnor C
    J Burn Care Res; 2014; 35(5):e357-63. PubMed ID: 24572296
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rituximab Therapy for Childhood Pemphigus Vulgaris.
    Kincaid L; Weinstein M
    Pediatr Dermatol; 2016; 33(2):e61-4. PubMed ID: 26765543
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Beware of anal fissures: pemphigus vulgaris of the anal canal.
    Karatzi C; Stefanidou M; Islamidou E; Kouvidou C; Chaniotis V; Evangelou G; Krueger-Krasagakis S; Athanasakis E; Krasagakis K
    Ann Gastroenterol; 2019; 32(2):205-207. PubMed ID: 30872911
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical efficacy of rituximab in the treatment of pemphigus: A retrospective study.
    Sharma VK; Bhari N; Gupta S; Sahni K; Khanna N; Ramam M; Sethuraman G
    Indian J Dermatol Venereol Leprol; 2016; 82(4):389-94. PubMed ID: 27279296
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pemphigus vulgaris and complications of systemic corticosteroid therapy: a case report.
    Sakallioglu EE; Acikgoz G; Keles G; Senturk N; Karagoz F
    J Oral Sci; 2003 Sep; 45(3):165-9. PubMed ID: 14650582
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use of rituximab as an adjuvant in the treatment of oral pemphigus vulgaris.
    Fortuna G; Calabria E; Ruoppo E; Adamo D; Aria M; Amato M; Mignogna MD
    J Oral Pathol Med; 2020 Jan; 49(1):91-95. PubMed ID: 31420993
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Unexpected worsening of pemphigus vulgaris after rituximab: A report of three cases.
    Mahmoudi H; Balighi K; Tavakolpour S; Daneshpazhooh M
    Int Immunopharmacol; 2019 Jun; 71():40-42. PubMed ID: 30877872
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of cyclophosphamide, azathioprine, and cyclosporine (ciclosporin) as adjuvant drugs in pemphigus vulgaris.
    Olszewska M; Kolacinska-Strasz Z; Sulej J; Labecka H; Cwikla J; Natorska U; Blaszczyk M
    Am J Clin Dermatol; 2007; 8(2):85-92. PubMed ID: 17428113
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pemphigus vulgaris presented with cheilitis.
    Abbas Z; Safaie Naraghi Z; Behrangi E
    Case Rep Dermatol Med; 2014; 2014():147197. PubMed ID: 25328720
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of Guidelines for Management of Pemphigus: a Review of Systemic Corticosteroids, Rituximab, and Other Immunosuppressive Therapies.
    Zhao W; Wang J; Zhu H; Pan M
    Clin Rev Allergy Immunol; 2021 Dec; 61(3):351-362. PubMed ID: 34350539
    [TBL] [Abstract][Full Text] [Related]  

  • 37. First-line treatment of pemphigus vulgaris with a combination of rituximab and high-potency topical corticosteroids.
    Ingen-Housz-Oro S; Valeyrie-Allanore L; Cosnes A; Ortonne N; Hüe S; Paul M; Wolkenstein P; Chosidow O
    JAMA Dermatol; 2015 Feb; 151(2):200-3. PubMed ID: 25354242
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnosis and Treatment Challenges of an Atypical Case of Pemphigus vulgaris During the COVID-19 Pandemic.
    Banciu ML; Dobrica C; Malciu AM; Vâjâitu C; Voiculescu VM
    Cureus; 2022 Jan; 14(1):e21739. PubMed ID: 35251811
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dermatological Side Effects of Epidermal Growth Factor Receptor Inhibitors: 'PRIDE' Complex.
    Madke B; Gole P; Kumar P; Khopkar U
    Indian J Dermatol; 2014 May; 59(3):271-4. PubMed ID: 24891659
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute paronychia heralding the exacerbation of pemphigus vulgaris.
    Lee HE; Wong WR; Lee MC; Hong HS
    Int J Clin Pract; 2004 Dec; 58(12):1174-6. PubMed ID: 15646419
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.